Start-up

Cardior Pharmaceuticals GmbH

Hollerithallee 20
30419 Hannover
Germany

Contact

About Cardior Pharmaceuticals

Cardior Pharmaceuticals is an academic spin-off developing new therapeutics for the treatment and prevention of heart disease - the number one cause of death in the western world. Our lead development program is an oligonucleotide based inhibitor of a molecular master switch (microRNA) controlling pathological alterations of the heart following stress or injury - CDR-132X.

Product portfolio of Cardior Pharmaceuticals

Product portfolio

Show all

News about Cardior Pharmaceuticals

26-Mar-2024 | business & finance

Possible billion-euro deal: Novo Nordisk wants to acquire MHH spin-off

Cardior Pharmaceuticals is developing a drug for the treatment of heart failure. The Danish pharmaceutical group Novo Nordisk is planning to acquire the ...

Read news